September 29, 2025

SHILPA MEDICARE

Co receives CDSCO approval for a spray to reduce or stop bleeding during accident or injury

They also speak about the path to unlock value in API biz through Strategic investment/IPO

Biologics – Adalimumab – to start generating revenue

Shilpa Medicare receives CDSCO nod for a Tranexamic acid spray to treat injuries. MD Vishnukant Bhutada tells @blitzkreigm & @Nigel__DSouza they are the 1st manufacturers of the acid in India. Adds that China+1 is an important factor currently playing out.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may have missed

Radico Khaitan share price target

Radico Khaitan has a strong portfolio of brands which are scaling up well on strong traction. Buy for target price of ₹3560 (20% upside): ICICI Direct

September 28, 2025
Godrej Agrovet share price target

Godrej Agrovet’s valuations underplay strong momentum over FY26-28E, material upside ahead. Buy for target price of ₹980 (42% upside): ICICI Securities

September 27, 2025
Epack Durable share price target

Epack Durable is riding the growth wave with strategic alliances and expansion; initiate coverage with BUY for target price ₹525 (44.1% upside): Yes Securities

September 26, 2025
Minda Corporation share price target

Minda Corporation is a compelling long-term compounding opportunity. Buy for target price of ₹690 (19% upside): Axis Securities

September 25, 2025
Sri Lotus Developers share price target

Sri Lotus Developers and Realty is a proxy to Mumbai’s redevelopment story. Buy for target price of ₹250 (35% upside): Motilal Oswal

September 24, 2025
South Indian Bank share price target

South Indian Bank offers a compelling re-rating opportunity, trading at just 0.8x P/B, a steep discount to regional private peers. Buy for target price of ₹38 (29% upside): ICICI Direct

September 23, 2025